Press release
Global Urological Cancer Therapeutics Drugs Market Industry Data Analysis 2020-2025
The report on Urological Cancer Therapeutics Drugs market is a comprehensive study on global market analysis and insights. The report focuses on the emerging trends in the global and regional spaces on all the significant components, such as market capacity, cost, price, demand and supply, production, profit, and competitive landscape. The report analyzes past trends and future prospects in this report which makes it highly comprehensible for the analysis of the market. Moreover, the latest trends, product portfolio, demographics, geographical segmentation, and regulatory framework of the Urological Cancer Therapeutics Drugs market have also been included in the study.
Get a Sample Copy of this Report @ https://www.globalinforesearch.com/Global-Urological-Cancer-Therapeutics-Drugs_p490865.html
What the Urological Cancer Therapeutics Drugs market research report basically consists of?
The report gives a look at the recent developments and their innovations in the global Urological Cancer Therapeutics Drugs
The report presents the basic overview of the industry which includes the definition, manufacturing along with its applications.
The report mainly comprises the recent marketing factors that are crucial to keep an eye on to analyze the market performance to fuel the profitability and productivity of the industry.
The report enhances its focus on the estimates of 2020-2026 market development trends of the Global Urological Cancer Therapeutics Drugs
Furthermore, an analysis of arduous raw materials, demand and production value has been laid out.
Key Market Players:
Novartis
Celgene Corporation
AstraZeneca
Pfizer
Abbott Laboratories
Johnson & Johnson
Ferring Pharmaceuticals
Bristol-Myers Squibb
Astellas
Dendreon Corporation
Sanofi S.A.
GlaxoSmithKline plc
Roche Healthcare
Indevus Pharmaceuticals Inc
Ipsen
This research is a comprehensive way to understand the current landscape of the market, especially in 2020. Both top-down and bottom-up approaches are employed to estimate the complete market size. This will help all the market stakeholders to have a better understanding of the direction in which the market will be headed and future forecast.
Market segmentation:
Research analysts have studied and analyzed the report on these 3 segments which cover the market share, revenues, growth rate along with the other factors that uplift the growth rate in Global Urological Cancer Therapeutics Drugs market. This study will lead in identifying the high growth areas as well as in identifying the growth factors which are helping in leading these segments.
For Product type segment the report listed main product type:
Xofigo (radium Ra 223 dichloride)
Jevtana (cabazitaxel)
Inlyta (axitinib)
Votrient (pazopanib hydrochloride)
Sutent (sunitinib malate)
Zytiga (abiraterone acetate)
Xtandi (enzalutamide)
Opdivo (nivolumab)
Provenge (sipuleucel-T)
For Application segment the report listed main types:
Hospital
Medical Research Laboratory
Others
Major importance has been given to the status of the key segments. The segmentation also includes the various End Users of this industry.
Regional analysis:
Asia Pacific
North America
South America
Europe
MEA(Middle East and Africa)
The report examines market on domestic and global level. Global prominent players and their market strategies are compiled in this report to understand the market strategies. The report forecasts the market size of segments with respect to countries in Americas (US, Canada, and Rest of Americas), Europe (UK, Germany, and Rest of Europe), APAC (China and Rest of APAC), MEA (KSA, UAE, and Rest of MEA), and ROW. The major takeaways in the report are product segment analysis, application segment analysis, regional segment analysis and data of the major Urological Cancer Therapeutics Drugs Market players from around the world.
For any queries you can visit our website or can contact on: https://www.globalinforesearch.com/Global-Urological-Cancer-Therapeutics-Drugs_p490865.html
Reasons to purchase this report:
It provides market dynamics scenario along with growth opportunities in the forecast period.
It determines upcoming opportunities, threats and obstacles that can have an effect on the industry.
This report will help in making accurate and time bound business plans keeping in mind the economic shift.
To interpret the market competitive advantages of the industry as well as internal competitors.
To enhance the creation long term business plans.
Regional and country level analysis.
Segment wise market value and volume.
SWOT, PEST analysis along with the strategies adopted by major players.
Table of Content
1 Market Overview
1.1 Urological Cancer Therapeutics Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Urological Cancer Therapeutics Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Xofigo (radium Ra 223 dichloride)
1.2.3 Jevtana (cabazitaxel)
1.2.4 Inlyta (axitinib)
1.2.5 Votrient (pazopanib hydrochloride)
1.2.6 Sutent (sunitinib malate)
1.2.7 Zytiga (abiraterone acetate)
1.2.8 Xtandi (enzalutamide)
1.2.9 Opdivo (nivolumab)
1.2.10 Provenge (sipuleucel-T)
1.3 Market Analysis by Application
1.3.1 Overview: Global Urological Cancer Therapeutics Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Medical Research Laboratory
1.3.4 Others
1.4 Overview of Global Urological Cancer Therapeutics Drugs Market
1.4.1 Global Urological Cancer Therapeutics Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Celgene Corporation
2.2.1 Celgene Corporation Details
2.2.2 Celgene Corporation Major Business
2.2.3 Celgene Corporation SWOT Analysis
2.2.4 Celgene Corporation Product and Services
2.2.5 Celgene Corporation Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca SWOT Analysis
2.3.4 AstraZeneca Product and Services
2.3.5 AstraZeneca Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Abbott Laboratories
2.5.1 Abbott Laboratories Details
2.5.2 Abbott Laboratories Major Business
2.5.3 Abbott Laboratories SWOT Analysis
2.5.4 Abbott Laboratories Product and Services
2.5.5 Abbott Laboratories Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Product and Services
2.6.4 Johnson & Johnson Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Ferring Pharmaceuticals
2.7.1 Ferring Pharmaceuticals Details
2.7.2 Ferring Pharmaceuticals Major Business
2.7.3 Ferring Pharmaceuticals Product and Services
2.7.4 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business
2.8.3 Bristol-Myers Squibb Product and Services
2.8.4 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Astellas
2.9.1 Astellas Details
2.9.2 Astellas Major Business
2.9.3 Astellas Product and Services
2.9.4 Astellas Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Dendreon Corporation
2.10.1 Dendreon Corporation Details
2.10.2 Dendreon Corporation Major Business
2.10.3 Dendreon Corporation Product and Services
2.10.4 Dendreon Corporation Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sanofi S.A.
2.11.1 Sanofi S.A. Details
2.11.2 Sanofi S.A. Major Business
2.11.3 Sanofi S.A. Product and Services
2.11.4 Sanofi S.A. Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 GlaxoSmithKline plc
2.12.1 GlaxoSmithKline plc Details
2.12.2 GlaxoSmithKline plc Major Business
2.12.3 GlaxoSmithKline plc Product and Services
2.12.4 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Roche Healthcare
2.13.1 Roche Healthcare Details
2.13.2 Roche Healthcare Major Business
2.13.3 Roche Healthcare Product and Services
2.13.4 Roche Healthcare Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Indevus Pharmaceuticals Inc
2.14.1 Indevus Pharmaceuticals Inc Details
2.14.2 Indevus Pharmaceuticals Inc Major Business
2.14.3 Indevus Pharmaceuticals Inc Product and Services
2.14.4 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Ipsen
2.15.1 Ipsen Details
2.15.2 Ipsen Major Business
2.15.3 Ipsen Product and Services
2.15.4 Ipsen Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Urological Cancer Therapeutics Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Urological Cancer Therapeutics Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Urological Cancer Therapeutics Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Urological Cancer Therapeutics Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Urological Cancer Therapeutics Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Urological Cancer Therapeutics Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Urological Cancer Therapeutics Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
4.5 South America Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Urological Cancer Therapeutics Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Urological Cancer Therapeutics Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Urological Cancer Therapeutics Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Urological Cancer Therapeutics Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Urological Cancer Therapeutics Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Urological Cancer Therapeutics Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
6.3 UK Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
6.4 France Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Urological Cancer Therapeutics Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Urological Cancer Therapeutics Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Urological Cancer Therapeutics Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.5 India Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Urological Cancer Therapeutics Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Urological Cancer Therapeutics Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Urological Cancer Therapeutics Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Urological Cancer Therapeutics Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Urological Cancer Therapeutics Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Urological Cancer Therapeutics Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Urological Cancer Therapeutics Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Urological Cancer Therapeutics Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Urological Cancer Therapeutics Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Urological Cancer Therapeutics Drugs Price by Type (2015-2020)
11 Global Urological Cancer Therapeutics Drugs Market Segment by Application
11.1 Global Urological Cancer Therapeutics Drugs Sales Market Share by Application (2015-2020)
11.2 Global Urological Cancer Therapeutics Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Urological Cancer Therapeutics Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Urological Cancer Therapeutics Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Urological Cancer Therapeutics Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Urological Cancer Therapeutics Drugs Market Forecast (2021-2025)
12.2.2 Europe Urological Cancer Therapeutics Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Urological Cancer Therapeutics Drugs Market Forecast (2021-2025)
12.2.4 South America Urological Cancer Therapeutics Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Urological Cancer Therapeutics Drugs Market Forecast (2021-2025)
12.3 Urological Cancer Therapeutics Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Urological Cancer Therapeutics Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Urological Cancer Therapeutics Drugs Market Share Forecast by Type (2021-2025)
12.4 Urological Cancer Therapeutics Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Urological Cancer Therapeutics Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Urological Cancer Therapeutics Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
About Us:
GlobaI Info Research（GIR） is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
Contact US
Global Info Research
E-mail: report@globalinforesearch.com
Tel: +86-13660489451 00852-58197708(HK)
Add:FLAT/RM A 9/F SILVERCORP INTERNATIONAL TOWER 707-713 NATHAN ROAD MONGKOK KL HONG KONG
Website: http://www.globalinforesearch.com
Contact US
Global Info Research
E-mail: report@globalinforesearch.com
Tel: +86-13660489451 00852-58197708(HK)
Add:FLAT/RM A 9/F SILVERCORP INTERNATIONAL TOWER 707-713 NATHAN ROAD MONGKOK KL HONG KONG
Website: http://www.globalinforesearch.com
GlobaI Info Research（GIR） is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Urological Cancer Therapeutics Drugs Market Industry Data Analysis 2020-2025 here
News-ID: 2129917 • Views: …
More Releases from GLOBAL INFO RESEARCH
Multiphase Buck Regulator Market Share, Revenue, Price, Growth Rate Ranking Anal …
Global Info Research's report offers an in-depth look into the current and future trends in Multiphase Buck Regulator, making it an invaluable resource for businesses involved in the sector. This data will help companies make informed decisions on research and development, product design, and marketing strategies. It also provides insights into Multiphase Buck Regulator' cost structure, raw material sources, and production processes. Additionally, it offers an understanding of the regulations…
PFC Inductor Market Report:By Key Players, Types, Application, Forecast to 2031
Global Info Research announces the release of the report "Global PFC Inductor Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides a detailed overview of the PFC Inductor market scenario, including a thorough analysis of the PFC Inductor market size, sales quantity, average price, revenue, gross margin and market share.The PFC Inductor report provides an in-depth analysis of the competitive landscape, manufacturer's profiles, regional and…
Supercritical Foams Market Size, Competitor Ranking Analysis, Market Trend Forec …
On Sep 8, Global Info Research released "Global Supercritical Foams Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report includes an overview of the development of the Supercritical Foams industry chain, the market status of Supercritical Foams Market, and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Supercritical Foams.
According to our (Global Info Research) latest…
Amphiphilic Copolymers Market Size, Competitor Ranking Analysis, Market Trend Fo …
Global Info Research's report is a detailed and comprehensive analysis for global Amphiphilic Copolymers market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the Amphiphilic Copolymers market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
